- Approval Id
- 56b75931b8562a62
- Drug Approval Philippines Name
- Docvate
- Product Name
- Docvate
- Registration Number
- DRP-10815
- Brand Name
- Docvate
- Generic Name
- Multivitamins + Minerals
- Dosage Form
- Film Coated Tablet
- Dosage Strength
- Formulation Each film-coated tablet contains:
Ascorbic Acid, USP-85mg d-Alpha-Tocopheryl Acetate (Vitamin E), USP-21IU Niacinamide (Vitamin B1), USP-18mg Calcuum Pantothenate (Vitamin B1), USP-6mg Cholecalciferol (Vitamin D1), USP-200IU Pyridoxine Hydrochloride (Vitamin B6), USP-200IU Thiamine Mononitrate (Vitamin B1), USP-1.9mg Riboflavine-5-Phosphate Sadium (Vitamin B1),USP-1.4mg Folic Acid, USP-800mcg
Cyanexohalamin (Vitamin B12), USP-2.6mcg Calcium (as Calcium Carbonate and Calcium Hydrogen Phosphate Anhydrous), USP-125mg trou (equivalent to 182 5440mg Famous Fumarate), USP-60mg Magnesium (equivalent to 165.x5mg Magnesium Oxide), USP-50mg Zinc (equivalent to 13.6873mg Zinc Oxide), USP-11mg Manganese (equivalait to 5.8452mg Manganese Sulfate Monohydrate), USP-1.90mcg Copper (equivalent to 2.6373mg Copper Sulfate Pantalıydrate), USP-1mg Modane (quivalent to 0,3022mg Potassium Iodide), USP-220mcg Sellenken (equivaleant to 0.1205mg Sodiun Scante), USP-50mcg
- Manufacturer
- Phil. United Pharma Corp. (PUPC)
- Trader
- Docteur's Choice Corporation
- Issuance Date
- 29 November 2021
- Expiry Date
- 29 November 2026
- Classification
- Over-the-Counter (OTC)
